Andera Partners


Andera Partners is a leading private equity firm with over 20 years of experience in helping companies achieve strong and sustainable growth. The firm specializes in private equity investments across various sectors, focusing on innovation, growth, and adaptation to rapidly changing environments. With a commitment to partnership and collaboration, Andera Partners aims to provide bespoke solutions to meet the challenges faced by business leaders. The firm manages over €4.5 billion in assets and has supported 350 companies, establishing itself as a key player in the European private equity market. In 2023, Andera Partners had a particularly active year, deploying €627 million, achieving €790 million in sales proceeds, and raising €680 million in new funds. The firm has set a target of managing €7 to €8 billion in assets by 2028, highlighting its European ambitions.

Andera Partners

Andera Partners


What We Do

A program dedicated to providing expertise, network, and tools to support investment companies in strategic advice, digital transformation, corporate social responsibility (CSR), M&A, and international development.


Fund Size

Investment Range

Investment Stage


Portfolio

Boston Scientific announced an agreement to acquire SoniVie Ltd.

#Medical Devices

Raised €27 million in a successful Series B co-led by Andera Partners and Bpifrance.

#Biotechnology

Announced a $89 million Series D financing round to support the clinical development of its lead candidates.

#Biopharmaceuticals

AstraZeneca will acquire Amolyt Pharma for up to $1.05 billion in total consideration.

#Biopharmaceuticals

AM-Pharma increases funding to €163 million for Phase III trial of recAP in SA-AKI.

#Biopharmaceuticals